Correlation Between Parker Hannifin and Barinthus Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both Parker Hannifin and Barinthus Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Parker Hannifin and Barinthus Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Parker Hannifin and Barinthus Biotherapeutics plc, you can compare the effects of market volatilities on Parker Hannifin and Barinthus Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Parker Hannifin with a short position of Barinthus Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Parker Hannifin and Barinthus Biotherapeutics.
Diversification Opportunities for Parker Hannifin and Barinthus Biotherapeutics
-0.48 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Parker and Barinthus is -0.48. Overlapping area represents the amount of risk that can be diversified away by holding Parker Hannifin and Barinthus Biotherapeutics plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Barinthus Biotherapeutics and Parker Hannifin is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Parker Hannifin are associated (or correlated) with Barinthus Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Barinthus Biotherapeutics has no effect on the direction of Parker Hannifin i.e., Parker Hannifin and Barinthus Biotherapeutics go up and down completely randomly.
Pair Corralation between Parker Hannifin and Barinthus Biotherapeutics
Allowing for the 90-day total investment horizon Parker Hannifin is expected to generate 0.25 times more return on investment than Barinthus Biotherapeutics. However, Parker Hannifin is 4.01 times less risky than Barinthus Biotherapeutics. It trades about 0.11 of its potential returns per unit of risk. Barinthus Biotherapeutics plc is currently generating about 0.0 per unit of risk. If you would invest 28,489 in Parker Hannifin on September 14, 2024 and sell it today you would earn a total of 39,768 from holding Parker Hannifin or generate 139.59% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Parker Hannifin vs. Barinthus Biotherapeutics plc
Performance |
| Timeline |
| Parker Hannifin |
| Barinthus Biotherapeutics |
Parker Hannifin and Barinthus Biotherapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Parker Hannifin and Barinthus Biotherapeutics
The main advantage of trading using opposite Parker Hannifin and Barinthus Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Parker Hannifin position performs unexpectedly, Barinthus Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Barinthus Biotherapeutics will offset losses from the drop in Barinthus Biotherapeutics' long position.| Parker Hannifin vs. Hurco Companies | Parker Hannifin vs. Enerpac Tool Group | Parker Hannifin vs. China Yuchai International | Parker Hannifin vs. Luxfer Holdings PLC |
| Barinthus Biotherapeutics vs. Mesa Air Group | Barinthus Biotherapeutics vs. Tesla Inc | Barinthus Biotherapeutics vs. Westinghouse Air Brake | Barinthus Biotherapeutics vs. BCE Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Complementary Tools
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |